Allogene Therapeutics (ALLO) Stock Chart & Stock Price History $1.90 -0.17 (-8.21%) (As of 05:26 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Allogene Therapeutics Stock Price Performance 5 Day Performance+7.41%1 Month Performance-5.58%3 Month Performance-29.51%6 Month Performance-8.97%Year-To-Date Performance-36.76%1 Year Performance-30.24% Receive ALLO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Allogene Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. ALLO Stock Chart for Wednesday, December, 18, 2024 ALLO Chart by TradingView Allogene Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/17/2024$2.06$2.07+0.49%$2.08$1.992.21 million shs$434.02 million12/16/2024$1.89$2.06+8.99%$2.09$1.923.08 million shs$431.92 million12/13/2024$2.02$1.89-6.44%$2.03$1.833.52 million shs$396.28 million12/12/2024$2.14$2.02-5.61%$2.13$2.002.73 million shs$423.54 million12/11/2024$2.19$2.14-2.28%$2.19$2.082.25 million shs$448.70 million12/10/2024$2.27$2.19-3.52%$2.31$2.181.88 million shs$459.18 million Get the Latest News and Ratings for ALLO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Allogene Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/09/2024$2.19$2.27+3.65%$2.35$2.162.69 million shs$475.96 million12/06/2024$2.14$2.19+2.34%$2.29$2.132.65 million shs$459.18 million12/05/2024$2.26$2.14-5.31%$2.22$2.101.87 million shs$448.69 million12/04/2024$2.32$2.26-2.59%$2.37$2.251.56 million shs$473.85 million12/03/2024$2.55$2.32-9.02%$2.52$2.292.28 million shs$486.43 million12/02/2024$2.48$2.55+2.82%$2.59$2.472.13 million shs$534.66 million11/29/2024$2.50$2.48-0.80%$2.54$2.451.53 million shs$519.98 million11/28/2024$2.50$2.50$2.62$2.482.26 million shs$524.18 million11/27/2024$2.52$2.50-0.79%$2.62$2.482.26 million shs$524.18 million11/26/2024$2.28$2.52+10.53%$2.77$2.445.30 million shs$528.37 million11/25/2024$2.21$2.28+3.17%$2.36$2.233.96 million shs$478.05 million11/22/2024$2.11$2.21+4.74%$2.23$2.091.42 million shs$463.37 million11/21/2024$2.05$2.11+2.93%$2.14$2.011.89 million shs$442.40 million11/20/2024$2.12$2.05-3.30%$2.14$1.992.44 million shs$429.82 million11/19/2024$2.15$2.12-1.40%$2.14$2.042.81 million shs$444.50 million11/18/2024$2.27$2.15-5.29%$2.32$2.142.92 million shs$450.80 million Related Companies NMRA Stock Chart BCRX Stock Chart NVAX Stock Chart IMCR Stock Chart MESO Stock Chart BLUE Stock Chart VIR Stock Chart ADPT Stock Chart PSTX Stock Chart IMTX Stock Chart Receive ALLO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Allogene Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALLO) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allogene Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allogene Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALLO Stock Alerts